Jerzy Vetulani

Q: What Schools Are Affiliated With Jerzy Vetulani

Jerzy Vetulani is affiliated with the following schools: Vanderbilt University, Jagiellonian University

Jerzy Vetulani's AcademicInfluence.com Rankings

Jerzy Vetulani

Biology

#3508

World Rank

#5360

Historical Rank

Neuroscience

#1119

World Rank

#1161

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Jerzy Vetulani Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jerzy Adam Gracjan Vetulani was a Polish neuroscientist, pharmacologist and biochemist, professor of natural sciences, member of the Polish Academy of Sciences and the Polish Academy of Learning, one of the most frequently cited Polish scientists in the field of biomedicine after 1965.

(See a Problem?)

Jerzy Vetulani's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain (1975) (598)
Mode of action of antidepressant drugs. (1978) (522)
Early maternal separation: a rodent model of depression and a prevailing human condition. (2013) (174)
Low doses of oxytocin facilitate social recognition in rats (2005) (166)
Antidepressants: past, present and future. (2000) (159)
ADAPTIVE MECHANISMS OF THE NORADRENERGIC CYCLIC AMP GENERATING SYSTEM IN THE LIMBIC FOREBRAIN OF THE RAT: ADAPTATION TO PERSISTENT CHANGES IN THE AVAILABILITY OF NOREPINEPHRINE (NE) 1, 2 (1976) (138)
Enhancement of responsiveness of the central serotonergic system and serotonin-2 receptor density in rat frontal cortex by electroconvulsive treatment. (1981) (117)
The noradrenergic cyclic AMP generating system in the limbic forebrain: pharmacological characterization in vitro and possible role of limbic noradrenergic mechanisms in the mode of action of antipsychotics. (1976) (105)
A possible common mechanism of action of antidepressant treatments (1976) (101)
Drug addiction. Part II. Neurobiology of addiction. (2001) (94)
Different action on dopamine catabolic pathways of two endogenous 1,2,3,4‐tetrahydroisoquinolines with similar antidopaminergic properties (2001) (86)
Depression by chronic electroconvulsive treatment of clonidine hypotherma and [3H]clonidine binding to rat cortical membranes. (1982) (84)
Effects of various Ca2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat. (1998) (77)
Opposite action of oxytocin and its peptide antagonists on social memory in rats (1991) (76)
Preliminary comparison of behavioral and biochemical effects of chronic transcranial magnetic stimulation and electroconvulsive shock in the rat (1997) (76)
Chronic administration of antidepressant drugs increases the density of cortical [3H]prazosin binding sites in the rat (1984) (73)
Head twitches induced by LSD and quipazine: Similarities and differences (1980) (65)
Chronic electroconvulsive treatment enhances the density of [3H]prazosin binding sites in the central nervous system of the rat (1983) (60)
Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone. (2004) (57)
Attenuation by chronic imipramine treatment of [3H]clonidine binding to cortical membranes and of clonidine-induced hypothermia: the influence of central chemosympathectomy (1982) (56)
The mechanism of 1,2,3,4‐tetrahydroisoquinolines neuroprotection: the importance of free radicals scavenging properties and inhibition of glutamate‐induced excitotoxicity (2006) (55)
Colostrinin, a Polypeptide Isolated From Early Milk, Facilitates Learning and Memory in Rats (1999) (53)
Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol (2000) (52)
1-methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain. (2003) (49)
RECOGNITION CUE IN THE RAT'S SOCIAL MEMORY PARADIGM (1991) (49)
Increased responsiveness of the cerebral cortical phosphatidylinositol system to noradrenaline and carbachol in senescent rats (1989) (47)
5‐Hydroxytryptamine‐like properties of m‐chlorophenylpiperazine: comparison with quipazine (1980) (46)
Facilitation and attenuation of social recognition in rats by different oxytocin-related peptides. (1996) (44)
Cortical dihydropyridine binding sites and a behavioral syndrome in morphine-abstinent rats. (1990) (40)
Enhancement of the responsiveness of cortical adrenergic receptors by chronic administration of the 5‐hydroxytryptamine uptake inhibitor citalopram. (1993) (40)
Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: advantage of a new high-performance liquid chromatography methodology (1997) (39)
Alpha up-beta down adrenergic regulation: a possible mechanism of action of antidepressant treatments. (1984) (39)
Complex action of antidepressant treatment on central adrenergic system: possible relevance to clinical effects. (1984) (38)
Repeated imipramine and electroconvulsive shock increase alpha 1A-adrenoceptor mRNA level in rat prefrontal cortex. (2002) (36)
Reduction of morphine dependence and potentiation of analgesia by chronic co-administration of nifedipine (2005) (36)
Opposite effect of simple tetrahydroisoquinolines on amphetamine- and morphine-stimulated locomotor activity in mice (2001) (36)
Postdecapitation convulsions in the rat measured with an Animex motility meter: relation to central alpha-adrenoceptors. (1982) (36)
Drug addiction. Part I. Psychoactive substances in the past and presence. (2001) (35)
Involvement of protein kinase c in the mechanism of in vitro effects of imipramine on generation of second messengers by noradrenaline in cerebral cortical slices of the rat (1991) (35)
Increase in rat cortical [3H]naloxone binding site density after chronic administration of antidepressant agents. (1984) (34)
Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages (1981) (34)
Reversal by imipramine of beta-adrenoceptor up-regulation induced in a chronic mild stress model of depression. (1994) (33)
Dopamine receptors in the striatum and limbic system of various strains of mice: Relation to differences in responses to apomorphine (1982) (33)
Diverse effects of GABA-mimetic drugs on cocaine-evoked self-administration and discriminative stimulus effects in rats (2007) (32)
The effect of multiple imipramine administration on monoaminergic systems of the rat brain. (1980) (32)
Analysis of the difference in the behavioral effects of apomorphine in C57BL/6 and DBA/2 mice (1982) (32)
Antagonism of clonidine to shaking behavior in morphine abstinence syndrome and to head twitches produced by serotonergic agents in the rat. (1978) (30)
A possible physiological role for cerebral tetrahydroisoquinolines (2009) (29)
Some pharmacological properties of N,N-disubstituted dithiocarbamates and their effect on the brain catecholamine levels. (1970) (28)
Various GABA-mimetic drugs differently affect cocaine-evoked hyperlocomotion and sensitization. (2006) (27)
Hyperthermic effect of intraventricular injections of arachidonic acid and prostaglandin E2 in the rat. (1974) (27)
Asymmetric behavioral and biochemical effects of unilateral injections of 6-hydroxydopamine into the lateral brain ventricle of the rat. (1972) (27)
Drug addiction. Part III. Pharmacotherapy of addiction. (2001) (26)
The Ca2+ Channel Blockade Changes the Behavioral and Biochemical Effects of Immobilization Stress (1999) (26)
The distribution of apomorphine in rat brain: possible behavioral correlates. (1978) (25)
The development of our understanding of the mechanism of action of antidepressant drugs. (1991) (25)
Role of calcium channels in effects of antidepressant drugs on responsiveness to pain (2005) (24)
[Biology of memory]. (1999) (24)
An endogenous neuroprotectant substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats (2007) (24)
3-Methoxytyramine, an extraneuronal dopamine metabolite plays a physiological role in the brain as an inhibitory regulator of catecholaminergic activity. (2008) (23)
Formalin hindpaw injection induces changes in the [3H]prazosin binding to α1-adrenoceptors in specific regions of the mouse brain and spinal cord (2005) (23)
Nicotine produces antidepressant-like actions: Behavioral and neurochemical evidence. (2005) (23)
The influence of rapid-rate transcranial magnetic stimulation (rTMS) parameters on rTMS effects in Porsolt's forced swimming test. (1999) (23)
The responsiveness of cerebral cortical adrenergic receptors after chronic administration of atypical antidepressant mianserin. (1994) (22)
Alpha-adrenergic receptor changes during antidepressant treatment. (2009) (20)
Pharmacokinetics of morphine in striatum and nucleus accumbens: Relationship to pharmacological actions (1985) (20)
Opiates and specific receptor binding of [3H]clonidine (1980) (20)
Different Mechanisms of β‐Adrenoceptor Down‐Regulation by Chronic Imipramine and Electroconvulsive Treatment: Possible Role for Protein Kinase C (1991) (20)
Effect of some N,N-disubstituted dithiocarbamates on catecholamines level in rat brain. (1969) (20)
Stimulatory and inhibitory action of clonidine on the locomotor activity in the rat. (1977) (18)
Retrieval associated cholinergic activity and its inhibition by memory updating. (1994) (18)
Brief maternal separation affects brain α1-adrenoceptors and apoptotic signaling in adult mice (2014) (18)
Effects of 1-methyl-1,2,3,4-tetrahydroisoquinoline on the behavioral effects of cocaine in rats. (2007) (18)
The difference in stress-induced analgesia in C57BL/6 and DBA/2 mice: a search for biochemical correlates. (1988) (17)
Cognitive effects of Colostral-Val nonapeptide in aged rats (2001) (17)
Nimodipine on Shuttle-box Avoidance Learning in Mice: No Impairment But Slight Improvement (1997) (17)
Effect of combined treatment with paroxetine and transcranial magnetic stimulation (TMS) on the mitogen-induced proliferative response of rat lymphocytes. (2002) (16)
Modification of effects of chronic electroconvulsive shock by voltage-dependent Ca2+ channel blockade with nifedipine. (1994) (16)
Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain. (1996) (15)
The effect of electroconvulsive shock and nifedipine on spatial learning and memory in rats (1994) (15)
The influence of electroshock on adrenoceptor function in rat brain cerebral cortex: selectivity for the alpha-adrenoceptor site. (1988) (14)
Does the presence of morphine counteract adaptive changes in expression of G-protein alpha subunits mRNA induced by chronic morphine treatment? (2007) (14)
Differences between haloperidol- and pimozide-induced withdrawal syndrome: a role for Ca2+ channels. (1995) (13)
Effect of repetitive electroconvulsive treatment on sensitivity to pain and on [3H]nitrendipine binding sites in cortical and hippocampal membranes (2005) (13)
Adaptive changes as the mode of action of antidepressant treatments. (1982) (13)
Haloperidol depresses the accumulation of apomorphine in the striatum of the rat. (1978) (12)
An in vivo procedure for the selective inactivation of rat brain cerebral cortical α-adrenoceptors using N-ethoxycarbonyl-2-ethoxy1,2-dihydroquinoline (EEDQ) (1989) (12)
Spaced electroconvulsive treatment: effects on responses associated with α2‐ and 5‐HT2–receptors (1983) (12)
Central Dopamine Receptors Regulate Blood Eosinophilia in the Rat (1979) (12)
The antagonistic effect of separate and consecutive chronic treatment with imipramine and ECS on the inhibition of alpha 1-adrenoceptor activity by protein kinase C. (1993) (11)
Negligible binding of 3H-clonidine to histamine H2 receptor. (1979) (11)
Behavioral effects and cerebral pharmacokinetics of apomorphine in the rat: dependence upon the route of administration. (1979) (11)
Comparison of effectiveness of two schedules of rapid transcranial magnetic stimulation on enhancement of responsiveness to apomorphine. (1999) (11)
Opioid-specific recognition sites of the mu- and the delta-type in rat striatum after lesions with kainic acid. (1984) (10)
Alpha-1-up, beta-down hypothesis: A counterproposal to Stone (1983) (10)
[Neurochemistry of impulsiveness and aggression]. (2013) (10)
Ca2+ channel blockade prevents lysergic acid diethylamide-induced changes in dopamine and serotonin metabolism. (1997) (10)
Modulation by Mianserin Pretreatment of the Chronic Electroconvulsive Shock Effects on the Adrenergic System in the Cerebral Cortex of the Rat (1996) (10)
Studies on the neurochemical basis of action of antidepressant drugs and electroconvulsive treatment. (1984) (9)
Strain differences in changes in some parameters of cerebral cortical adrenergic system following chronic imipramine administration to rats. (1991) (9)
The effect of calcium channel blockade on the action of chronic ECT and imipramine on responses of alpha 1- and beta-adrenoceptors in the rat cerebral cortex. (1993) (9)
Electroshock-induced increase in [3H]prazosin binding to cortical membranes in reserpinized rats. (1984) (9)
Changes in morphine pharmacokinetics in nervous and peripheral tissues following different schedules of administration. (1983) (9)
Effect of cocaine sensitization on alpha1-adrenoceptors in brain regions of the rat: an autoradiographic analysis. (2006) (9)
The effect of chronic imipramine and electroconvulsive shock treatment on [3H]DADLE binding to cortical membranes of rats pretreated with chronic reserpine or 6-hydroxydopamine (1987) (9)
Facilitation by α-adrenolytics of apomorphine gnawing behavior: Depression of threshold apomorphine concentration in the striatum of the rat (1983) (9)
Two possible binding sites for 3H-clonidine in the rat cerebral cortex. (1979) (9)
Minaprine, but not oxiracetam, prevents desipramine-induced impairment of avoidance learning in mice. (1995) (8)
Accumulation of apomorphine in caudate nucleus and hippocampus of the rabbit (1979) (8)
Effects of chronically administered antidepressants and electroconvulsive treatment on cerebral neurotransmitter receptors in rodents with 'model depression'. (1986) (8)
Co-administration of nifedipine with neuroleptics prevents development of activity changes during withdrawal. (1994) (8)
Carane derivative stereoisomers of different local anaesthetic and antiplatelet activity similarly potentiate forskolin‐stimulated cyclic AMP response and bind to β‐adrenoceptors in the rat brain cortex (2004) (8)
Stimulatory effect of chlordiazepoxide on locomotor activity in mice: importance of noradrenergic transmission. (1978) (8)
Conditions of application of repeated transcranial magnetic stimulation to rats may mask the effects of the treatment. (2001) (8)
The effect of quipazine and LSD on monoamines in the rat striatum. (1979) (8)
Changes induced by formalin pain in central α1-adrenoceptor density are modulated by adenosine receptor agonists (2010) (8)
Neurochemical correlates of differences in responses to psychotropic drugs. I. Apomorphine and morphine effects on locomotor activity of C57/BL and Balb/C mice. (1989) (8)
Does Ca2+ channel blockade modulate the antidepressant-induced changes in mechanisms of adrenergic transduction? (2005) (7)
Plasticity of extrapyramidal dopamine system in Parkinson's disease ‐ A postmortem study (1999) (7)
Effect of naloxone on the locomotor stimulatory action of chlordiazepoxide in mice (1988) (7)
Pentobarbital-induced hyperactivity in mice: Negligible role of opioid mechanisms (1989) (7)
Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa. (1973) (7)
Preliminary study of the biotransformation of two new drugs, trazodone and etoperidone. (1980) (7)
Opiate and alpha 1-adrenergic receptors in mice responding to morphine with sedation or with running fit. (1991) (7)
Similar action of imipramine and arginine-vasopressin in the social interaction test. (1993) (7)
Antihistaminics enhance morphine-, but not amphetamine-and scopolamine-induced hyperactivity in mice (2004) (7)
[The behavioral effects of the transcranial magnetic brain stimulation in rat: the comparison with electroshock]. (2000) (7)
The effect of calcium channel blockade during electroconvulsive treatment on cerebral cortical adrenoceptor subpopulations in the rat. (1993) (6)
Stability and variability of locomotor responses of laboratory rodents. IV. The responses of rats and mice to apomorphine and amphetamine. (1988) (6)
The effect of dopamine-beta-hydroxylase inhibitors, dimethylphenylthiourea and fusaric acid, on locomotor and exploratory activity, body temperature, and regional distribution of biogenic amines in the rat brain. (1973) (6)
Modulation of electroconvulsive treatment induced beta-adrenergic down-regulation by previous chronic imipramine administration: the involvement of protein kinase C. (1996) (6)
Head twitches produced by serotonergic drugs and opiates after lesion of the mesostriatal serotonergic system of the rat. (1979) (6)
Inhibition by clonidine of morphine-induced running fit but not analgesia in C57BL/6 mice. (1980) (6)
Tetrahydroisoquinolines as endogenous neurotoxins and neuroprotectants (2001) (6)
Intraventricular injections of L-dopa: the effect on rat locomotor activity and body temperature. (1973) (6)
Stability and variability of locomotor responses of laboratory rodents. II. Native exploratory and basal locomotor activity of Wistar rats. (1987) (6)
Conditioned rewarding stimulus associated with cocaine self-administration reverses the depression of catecholamine brain systems following cocaine withdrawal in rats. (2005) (6)
Caffeine interferes with morphine-induced hyperactivity but not analgesia. (1983) (6)
Motor depression and head twitches induced by IP injection of GABA (2004) (5)
The role of trazodone metabolism in its inhibitory action on avoidance response (1985) (5)
Behavioral and biochemical effects of intraventricular kainic acid. (1980) (5)
The effect of morphine dependence and abstinence on opioid receptors in the cerebral cortex and spinal cord of the rat. (1988) (5)
Morphine-induced place preference affects mRNA expression of G protein α subunits in rat brain. (2012) (5)
Stability and variability of locomotor responses of laboratory rodents. III. Effect of environmental factors and lack of catecholamine receptor correlates. (1988) (5)
[Salsolinol, 3-O-methyl-dopa and homovanillic acid in the cerebrospinal fluid of Parkinson patients]. (1997) (5)
The effect of chronic administration of amitriptyline on the effects of subsequent electroconvulsive treatment on responsiveness of α1- and β-adrenoceptors in the rat cortical slices (2005) (5)
A comparison of locomotor responses to some psychotropic drugs and cerebral receptors in the Acomys cahirinus and the laboratory mouse. (1987) (5)
Haloperidol-induced changes in the regional cerebral pharmacokinetics of apomorphine. (1979) (5)
Improvement of shuttle-box performance of mice by combinations of benzodiazepines and morphine given during training. (1977) (5)
Pretreatment with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline accelerates the electroshock-induced decrease in density of β-adrenoceptors but not functional downregulation (1990) (5)
Social memory and neurohypophyseal hormones (1993) (5)
Modification of morphine analgesia, tolerance and abstinence by 1,2,3,4-tetrahydroisoquinoline (2003) (5)
Short- and long-term effects of intraventricular 6-hydroxydopamine in rats pretreated with a monoamine oxidase inhibitor. (1977) (5)
Inhibition of "wet shakes" during morphine abstinence by an antagonist of opiate analgesia. (1978) (5)
Fear memory-induced alterations in the mRNA expression of G proteins in the mouse brain and the impact of immediate posttraining treatment with morphine (2019) (5)
The effect of chronic administration of trazodone on the acquisition of avoidance behavior in mice. (1985) (4)
Different effects of 3-chlorophenylpiperazine on locomotor activity and acquisition of conditioned avoidance response in different strains of mice (1982) (4)
Second messengers: rate of formation as an index of receptor reactivity. (1990) (4)
Reserpinization enhances electroconvulsive treatment effects on cortical α1-adrenoceptors (1988) (4)
Spaced electroconvulsive treatment: effects on responses associated with alpha 2- and 5-HT2-receptors. (1983) (4)
The interaction of tetrahydroisoquinoline derivatives with antinociceptive action of morphine and oxotremorine in mice (2003) (4)
Stability and variability of locomotor responses of laboratory rodents. I. Native exploratory and basal locomotor activity of Albino-Swiss mice. (1987) (4)
A role of the polysynaptic system of substantia nigra in the cholinergic-dopaminergic equilibrium in the central nervous system (1978) (4)
Facilitation of shuttle-box avoidance behaviour in mice treated with nifedipine in combination with amphetamine (2005) (4)
Effect of electroconvulsive treatment on cerebral opioid receptors in the rat: Changes in δ but not μ receptors (1984) (4)
Opposite action of m-chlorophenylpiperazine on avoidance depression induced by trazodone and pimozide in CD-1 mice (2004) (4)
Shuttle-box avoidance behavior of mice treated with nifedipine in combination with nicotine or physostigmine. (1994) (4)
Chronic treatment with the potential antidepressant drug rolipram: the effect on the behavioural responses to adrenergic and dopaminergic receptor agonists with some biochemical correlates (2005) (3)
Effect of clonidine on the noradrenergic cyclic AMP generating system in the limbic forebrain and on medial forebrain bundle self-stimulation behavior (1977) (3)
A toggle-floor box: the reliability of crossings in the evaluation of drug-induced locomotor changes in mice. (1988) (3)
The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine. (1973) (3)
Chronic dosage of imipramine in animal experiment: concentrations of imipramine and desipramine in the rat brain after various modes of dosage. (1985) (3)
Electroconvulsive shock-induced impairment of spatial learning is aggravated by nifedipine. (1993) (3)
Effects of excitatory amino acids on inositol phosphate accumulation in slices of the cerebral cortex of young and aged rats (1993) (3)
Increased low-affinity 3H-spiroperidol binding to rat cortical membranes after chronic antidepressant treatments. (1985) (3)
Current Concepts of Mechanisms of Action of Antidepressant Treatments Based on Preclinical Studies (1998) (3)
Pharmacological and biochemical studies on binodaline. (1983) (3)
Differential involvement of voltage-dependent calcium channels in apomorphine-induced hypermotility and stereotypy (2005) (3)
Facilitation of avoidance behavior by chlordiazepoxide and chlordiazepoxide-amphetamine combination: effect on performance. (1980) (3)
Facilitation of stimulatory effect of chlordiazepoxide-amphetamine combination by subacute administration of chlordiazepoxide in mice (2004) (3)
Psychopharmacology of clonidine (1983) (3)
[Transcranial magnetic stimulation versus electroconvulsive shocks: neuroanatomical investigations in rats]. (2000) (3)
The difference in the tail-flick but not hot-plate response latency between C57BL/6 and DBA/2J mice. (1988) (3)
Paroxetine pretreatment does not change the effects induced in the rat cortical beta-adrenergic receptor system by repetitive transcranial magnetic stimulation and electroconvulsive shock. (2010) (3)
The ineffectiveness of desipramine pretreatment on behavioral effects of 6-hydroxydopamine in nialamide-pretreated rats (2004) (3)
Effects of chlordiazepoxide on acquisition of avoidance behaviour in mice receiving chronically antidepressant drugs. (1981) (3)
A comparison of norepinephrine stimulated inositol phosphate accumulation in cerebral cortex of the Acomys cahirinus, the laboratory mice and the rat. (1988) (2)
Differences in beta-adrenergic regulation of cyclic AMP formation in cerebral cortical slices of the rat and spiny mouse--Acomys cahirinus. (1990) (2)
Different mechanisms of beta-adrenoceptor down-regulation by chronic imipramine and electroconvulsive treatment: possible role for protein kinase C. (1991) (2)
Effect of electroconvulsive treatment on cerebral opioid receptors in the rat: changes in delta but not mu receptors. (1984) (2)
Haloperidol treatment selectively affects expression of Galpha(i)3 subunit mRNA in specific regions of the rat brain. (1999) (2)
Differences in effects of Ca2+ channel antagonists on dopamine metabolism in the limbic and extrapyramidal dopaminergic structures (1996) (2)
Repeated treatment with antidepressant drugs does not affect the benzodiazepine receptors in preincubated membrane preparations from mouse and rat brain (1987) (2)
[Neuropeptides and neurotransmission]. (1985) (2)
The action of antidepressant drugs administered during calcium channel blockade. (1993) (2)
1-Methyl-1,2,3,4-Tetrahydroisoquinoline: A Potent Neuroprotecting Agent (2012) (2)
β Down-regulation induced by repeated vasopressin treatment (1990) (2)
Lack of effect of chronic imipramine administration on beta-adrenoceptor density on rat lymphocytes. (1986) (2)
Changes in action of tricyclic and tetracyclic antidepressants: Desipramine and mianserin, on avoidance behavior in the course of the chronic treatment (2004) (2)
[Behavioral and biochemical effects of magnetic brain stimulation and electroshock in rats]. (1996) (2)
The involvement of voltage-dependent calcium channel in the mechanism of ECS action (1994) (2)
CALCIUM CHANNEL ANTAGONIST INTERACTIONS WITH ANTIDEPRESSANTS, OPIOIDS AND DRUGS AFFECTING DOPAMINERGIC NEURONS (1992) (1)
Locomotor activity pattern induced by diazepam in control and caffeine-treated mice. (1995) (1)
Further dissociation between the memory-facilitating effects of low and memory-attenuating effects of high doses of oxytocin. A structure-activity study (1992) (1)
THE KINASE C ACTIVATION DOES NOT POTENTIATE FURTHER THE NORADRENALINE-INDUCEDCYCLIC AND RESPONSE AUGMENTED BY CHEMOSYMPATHECTOMY (1992) (1)
Immediate and "day-after" effects of morphine on dopamine and serotonin metabolism in various structures of the rat brain. (1995) (1)
Synthesis, antiarrhythmic and α-adrenoreceptor blocking activity of novel 1-[(2-hydroxy-3-amino-)]-propylpyrrolidin-2-one derivatives (1996) (1)
Neurobiology and psychopharmacology of the soul (2010) (1)
Blockade by nifedipine of repeated restraint stress-induced delayed hyperactivity in rats. (1997) (1)
Central action of amitriptyline N-oxide. (1982) (1)
Shuttle-box avoidance facilitation by minaprine in mice. (1990) (1)
[Biological basis of psychiatry]. (2001) (1)
Different calcium requirements during incorporation of myo-inositol into membrane lipids for phosphatidylinositol hydrolysis stimulated by carbachol and noradrenaline. (1990) (1)
Beta down-regulation induced by repeated vasopressin treatment. (1990) (1)
Behavioral and pharmacokinetic interaction between morphine and haloperidol in the rat. (1984) (1)
Pharmacological receptors: the membrane receptors for neurotransmitters and drugs. (1988) (1)
Differences in adrenergic regulation of cyclic AMP formation in cerebral cortex of the spiny mouse /Acomys cahirimus/ and the rat (1992) (0)
EFFECTS OF DRUGS AFFECTING SEROTONERGIC SYSTEM ON ACTIVITIES OF CENTRAL DOPAMINERGIC AND SEROTONERGIC SYSTEMS IN RATS (1980) (0)
P-2 Effects of electroconvulsive seizures on protein kinase C-induced potentiation of cyclic AMP response are modified by pretreatment with antidepressant drugs (1996) (0)
Nicotine potentiates imipramine-induced effects on catecholamine metabolism: possible relation to antidepressant activity. (2006) (0)
In vitro effects of antidepressants on noradrenaline-dependent second messenger systems (1992) (0)
P.6.d.016 Changes in expression of G protein alpha subunits' mRNAs in rat amygdala after cocaine self-administration, withdrawal and the drug-or cue-induced reinstatement (2006) (0)
Opiate A and B receptors in the rat striatum. (1980) (0)
High doses of morphine do not change characteristics of the cerebral catecholamine receptors in the rat. (1988) (0)
BEHAVIORAL AND BIOCHEMICAL STUDIES ON AZIDOMORPHINES. I. BEHAVIORAL ACTIONS AND ANTAGONISM OF ABSTINENCE SYNDROMES (1980) (0)
14-144 Potentiation of morphine analgesia and inhibition of dependence development by Ca2+ channel antagonists (1997) (0)
ADRENERGIC AND NON-ADRENERGIC RECEPTOR SYSTEM ADAPTATIONS TO CHRONIC ANTIDEPRESSANT TREATMENTS (1984) (0)
P-52 The importance of voltage-dependent calcium channel in withdrawal effects after chronic treatment with haloperidol (1996) (0)
P69 1-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE (1METIQ) INHIBITS CONDITIONED MORPHINE REWARD IN MICE (2004) (0)
Neurobiology of drug addiction (2001) (0)
The action of neuroleptics in rats with altered catecholamine metabolism. 3. The effect of chlorpromazine, haloperidol and thioridazine on the brain dopamine and serotonin contents in the rats pretreated with MAO inhibitors. (1973) (0)
The action of neuroleptics in rats with altered catecholamine metabolism. IV. Behavioral and biochemical effects of chlorpromazine and haloperidol in rats pretreated with inhibitors of dopamine-beta-hydroxylase. (1973) (0)
Effect of repetitive administration of morphine on G alpha(q), G alpha(11) and G alpha(12) genes' expression in the rat prefrontal cortex (2003) (0)
L-5 Critical progress in MAO inhibition in the treatment of mood disorders (1996) (0)
Combined treatment with paroxetine and transcranial magnetic stimulation (TMS) depresses the mitogen-induced proliferation of rats' thymocytes and splenocytes (2002) (0)
Schizophrenia: A biologist's perspective (2007) (0)
Role of cyclic nucleotides in receptor mechanisms (2004) (0)
Nifedipine modulates some changes induced by antidepressants in adrenergic transmission at the second messengers level (1997) (0)
The Effect of Trazodone and Its Metabolite, CPP, on Acquisition of Conditioned Avoidance Response (1986) (0)
The effect of single 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MTIQ) administration on concentration of noradrenaline and dopamine in the mouse and rat brain (2001) (0)
Reserpinization enhances electroconvulsive treatment effects on cortical alpha 1-adrenoceptors. (1988) (0)
Chronic electroconvulsive treatment counteracts cortical beta-adrenoceptor upregulation induced by morphine abstinence. (1991) (0)
Zmierzch testu LD50 (2001) (0)
The action of neuroleptics in rats with altered catecholamine metabolism. II. The effects of chlorpromazine, haloperidol, and thioridazine on brain noradrenaline content elevated by previous administration of MAO inhibitors. (1973) (0)
Paroxetine pretreatment does not affect the behavioral and biochemical effects of chronic electroconvulsive shock in rats (2002) (0)
THE EFFECT OF CHRONIC CITALOPRAM TREATMENT ON SECOND MESSENGER SYSTEMS AND KINASE C ACTIVATION IN THE RAT CEREBRAL CORTEX. (1992) (0)
The development of understanding of the mechanism of action of antidepressant drugs. (1989) (0)
Pharmacological implications of the influence of calcium channel blockade on neurotransmitter systems (1992) (0)
Adrenergic receptors' responsiveness after acute and chronic treatment with haloperidol in the presence of calcium channel blockade. (1999) (0)
3H-dihydromorphine binding sites in subcellular fractions of rat striatum. (1982) (0)
[Preliminary studies of the adrenergic receptors in the human right atrium]. (1984) (0)
Involvement of L-type voltage-dependent calcium channel in apomorphine motility but not stereotypy (1994) (0)
The difference in the tail-flick latency between C57BL/6 and DBA/2J mice. (1988) (0)
Neuroleptics: from the receptors to nucleus (1999) (0)
[Biochemical presynaptic and receptor adaptations during long-term antidepressive treatment]. (1987) (0)
[Pharmacology of isoxazole and pyrazole derivatives]. (1968) (0)
39-71 Parkinson's disease: Salsolinol level and dopamine metabolism in the CSF and brain structures (1997) (0)
The behavioral and neurochemical consequences of chronic administration of LSD: prevention of dopamine metabolism disturbances and cognitive impairment by Ca2+ channel blockade (1997) (0)
455 – OPIATE RECEPTORS INVOLVED IN DRUG DEPENDENCE: CHARACTERIZATION WITH AN AZIDOMORPHINE DERIVATIVE, N-CYCLOPROPYLMETHYLNORAZLDOMORPHINE (CAM) (1978) (0)
CHANGES IN ALPHA2 - ADRENORECEPTOR DENSITY AFTER CHRONIC TREATMENT WITH IMIPRAMINE (1980) (0)
Tolerance to diazepam-induced avoidance depression in mice. (1987) (0)
CHANGES IN STRIATAL AND MESOLIMBIC DOPAMINE RECEPTORS AFTER SINGLE IN VIVO ADMINISTRATION OF MORPHINE (1980) (0)
[Memory mechanisms and expectancy of therapy in Alzheimer's disease]. (2000) (0)
BEHAVIORAL AND BIOCHEMICAL STUDIES ON AZIDOMORPHINES. II. ACTION ON OPIATE AND CATECHOLAMINE RECEPTORS (1980) (0)
Cataleptogenic doses of morphine suppress 3H-spiroperidol binding to striatal membranes (1982) (0)
Janusz Supniewski as a researcher of psychotrophic drugs (on his 100th birthday). (2000) (0)
Distinct differences in neurochemical effects produced by various 1,2,3,4-tetrahydroisoquinolines on dopaminergic structures of rat brain (2000) (0)
Some pharmacological properties of 2-methyl-2-butene-carboxylic acid (1959) (0)
[The role of the central dopaminergic system in the mechanisms of action of antidepressive drugs and electroconvulsive therapy]. (1988) (0)
61-5 Nifedipine prevents neurochemical and cognitive changes induced by chronic lysergic acid diethylamide in rodents (1997) (0)
Phorbol ester and central chemosympathectomy augment beta-adrenoceptor response by different mechanisms. (1993) (0)
O-18-3 Specific activation of limbic dopaminergic structures in rat brain by Ca2+ channel blockers (1996) (0)
The lack of effect of chronic administration of imipramine and electroconvulsive shock on opioid mu, delta and kappa receptors in the spinal cord. (1987) (0)
P.2.d.010 Single and chronic agomelatine treatment differently affect cerebral a1-adrenergic receptors (2009) (0)
Effect of experimental encephalomyelitis on the alfa subunit of the Gs protein in the central nervous system (1999) (0)
A healer, a scientist, a fighter, an artist (2012) (0)
Dopaminergic and serotonergic mechanism in ECS (1994) (0)
P-18-8 Modulation by nifedipine of ECS action on second messenger and protein kinase C-related effects (1996) (0)
[Neuroleptics, monoamine oxidase inhibitors and dopamine beta hydroxylase inhibitors: their actions and interactions]. (1973) (0)
[Neuroleptics--phenothiazine and butyrophenone derivatives]. (1969) (0)
EFFECTS OF DRUGS AFFECTING SEROTONERGIC SYSTEM ON ACTIVITY OF CENTRAL DOPAMINERGIC AND SEROTONERGIC SYSTEMS IN RATS (1980) (0)

This paper list is powered by the following services:

Other Resources About Jerzy Vetulani

en.wikipedia.org

What Schools Are Affiliated With Jerzy Vetulani?

Jerzy Vetulani is affiliated with the following schools:

Jerzy Vetulani's Academic­Influence.com Rankings